These data confirm that CD8+ T cells are indispensible in this RT model even in the presence of dual CCR2/CCR5 inhibition, and suggest that CVC therapy is likely amplifying an existing radiation-induced anti-tumor T cell response. Here, CD8A is linked to neoplasm.